Società Prodotti Antibiotici

Società Prodotti Antibiotici (SPA) is a private Italian pharmaceutical company founded in 1947 and headquartered in Milan. While its name reflects its historical origins in antibiotic production, the company has evolved into a diversified healthcare entity focusing on cardiovascular, osteoarticular, and urological therapeutic areas. SPA is recognized for the development and commercialization of significant drugs such as the anti-arrhythmic agent flecainide (Almarytm) and the corticosteroid deflazacort (Deflan). The company maintains integrated capabilities encompassing research, development, and GMP-certified manufacturing at its Milan facility. SPA serves both the Italian national health system and international markets through a network of distributors and partners.